# Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

> **NCT03496402** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut Curie** · enrollment: 600 (estimated)

## Conditions studied

- Neuroblastoma
- Rhabdomyosarcoma
- Ewing Sarcoma Family of Tumors
- Osteosarcoma
- Leukemia
- Central Nervous System Tumor

## Interventions

- **OTHER:** Sampling on blood, bone marrow and cerebrospinal fluid

## Key facts

- **NCT ID:** NCT03496402
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-20
- **Primary completion:** 2027-04-19
- **Final completion:** 2027-08-19
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03496402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03496402, "Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03496402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*